| Literature DB >> 31496458 |
Kamelia Harris1, Patricia Gooding2, Gillian Haddock3, Sarah Peters2.
Abstract
BACKGROUND: Suicide is a leading cause of premature death in people with a diagnosis of schizophrenia. Although exposure to stressors can play a part in the pathways to death by suicide, there is evidence that some people with a diagnosis of schizophrenia can be resilient to the impact of suicide triggers. AIMS: To investigate factors that contribute to psychological resilience to suicidal thoughts and behaviours from the perspectives of people with a diagnosis of schizophrenia.Entities:
Keywords: Psychological resilience; psychosis; schizophrenia; suicidal behaviours; suicidal thoughts
Year: 2019 PMID: 31496458 PMCID: PMC6737512 DOI: 10.1192/bjo.2019.63
Source DB: PubMed Journal: BJPsych Open ISSN: 2056-4724
Participant characteristics
| Characteristic | Value |
|---|---|
| Age | |
| Years, mean (s.d.) | 48 (15.5) |
| Years, range | 23–75 |
| Gender, women: % ( | 50 (10) |
| Ethnicity, % ( | |
| White British | 80 (16) |
| Black British | 5 (1) |
| Mixed ethnicity | 15 (3) |
| Occupation, % ( | |
| Unemployed | 55 (11) |
| Self-employed | 5 (1) |
| Retired | 20 (4) |
| Volunteer | 5 (1) |
| Student | 5 (1) |
| Living arrangements, % ( | |
| Supported accommodation | 25 (5) |
| Rehabilitation unit | 5 (1) |
| Alone | 40 (8) |
| With family | 25 (5) |
| With carer | 5 (1) |
| Suicidal experiences, % ( | |
| Lifetime | 100 (20) |
| Current (at the time of interview) | 20 (4) |
| Duration of illness | |
| Years, mean (s.d.) | 22.2 (13.2) |
| Years, range | 0.4–43 |
| Current diagnosis, % ( | |
| Schizophrenia | 25 (5) |
| Paranoid schizophrenia | 40 (8) |
| Chronic schizophrenia | 5 (1) |
| Treatment resistant schizophrenia | 5 (1) |
| Schizoaffective disorder | 10 (2) |
| Psychotic disorder | 5 (1) |
| Acute psychosis | 5 (1) |
| Unspecified non-organic psychosis | 5 (1) |
| Medication, | |
| Clozapine | 25 (5) |
| Aripiprazole | 40 (8) |
| Quetiapine | 5 (1) |
| Olanzapine | 10 (2) |
| Zuclopenthixol | 10 (2) |
| Flupentixol | 10 (2) |
| Risperidone | 5 (1) |
| Fluphenazine | 5 (1) |
| Amisulpride | 5 (1) |
Based on data from 19 participants.
Some participants were prescribed two types of antipsychotic medication.
Fig. 1Conceptual model including factors that contribute to psychological resilience to suicidal thoughts and behaviours in people with schizophrenia diagnoses.
| Criterion | Description |
|---|---|
| 1. | 18 years or older. |
| 2. | Capacity to provide informed consent. |
| 3. | English speaking. |
| 4. | Schizophrenia diagnosis (i.e. schizophrenia, schizophreniform disorder, schizoaffective disorder, delusional disorder or psychotic disorders not otherwise specified) or experiences of non-affective psychosis, confirmed by a member of the individual's mental health team. |
| 5. | Lifetime experience of suicidal thoughts and/or behaviours. Lifetime suicidal experiences were reported by individuals who self-referred to the study themselves, or by mental health professionals who identified potential participants. |
| 6. | Contact with a National Health Service mental health team. |
| Resilience model | Description |
|---|---|
| Unidimensional (‘two poles’) | Includes risk (for example hopelessness) at one end of the dimension and a lack of risk (for example no hopelessness) at the other end of the dimension. |
| Two-dimensional (buffering) | Includes resilience factors that weaken/moderate the relationships between suicide triggers (for example negative stressors) and suicidal thoughts and acts. |
| Recovery | Incorporates regain of psychological functioning that occurs either during or following the experience of negative events or stressors. |
| Maintenance | Involves an ability to sustain a positive outlook despite negative stressors, in the long term. |
| Psychological immunity | Involves immunity to negative events or stressors (i.e. individuals' well-being is not affected by negative stressors). |